A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated with Huntington's Disease
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Neurocrine Biosciences, Inc.
Start Date
October 3, 2019
End Date
August 23, 2022
Administered By
Neurology, Movement Disorders
Awarded By
Neurocrine Biosciences, Inc.
Start Date
October 3, 2019
End Date
August 23, 2022